The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans
Open accessAbstract
Bile acids are synthesized from cholesterol in the liver and subjected to multiple metabolic biotransformations in hepatocytes, including oxidation by cytochromes P450 (CYPs) and conjugation with taurine, glycine, glucuronic acid, and sulfate. Mice and rats can hydroxylate chenodeoxycholic acid (CDCA) at the 6β-position to form α-muricholic acid (MCA) and ursodeoxycholic acid (UDCA) to form β-MCA. However, MCA is not formed in humans to any appreciable degree and the mechanism for this species difference is not known. Comparison of several Cyp-null mouse lines revealed that α-MCA and β-MCA were not detected in the liver samples from Cyp2c-cluster null (Cyp2c-null) mice. Global bile acid analysis further revealed the absence of MCAs and their conjugated derivatives, and high concentrations of CDCA and UDCA in Cyp2c-null mouse cecum and feces. Analysis of recombinant CYPs revealed that α-MCA and β-MCA were produced by oxidation of CDCA and UDCA by Cyp2c70, respectively. CYP2C9-humanized mice have similar bile acid metabolites as the Cyp2c-null mice, indicating that human CYP2C9 does not oxidize CDCA and UDCA, thus explaining the species differences in production of MCA. Because humans do not produce MCA, they lack tauro-β-MCA, a farnesoid X receptor antagonist in mouse that modulates obesity, insulin resistance, and hepatosteatosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sayin, S. I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., & Bäckhed, F. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.003 · Cited by 2,331
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069
TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., Macchiarulo, A., Yamamoto, H., Mataki, C., Pruzanski, M., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.001 · Cited by 1,885
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
Buffie, C. G., Bucci, V., Stein, R. R., McKenney, P. T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., et al. (2015) · Nature · doi:10.1038/nature13828 · Cited by 1,872
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Nelson, D. R., Zeldin, D. C., Hoffman, S. M., Maltais, L. J., Wain, H. M., & Nebert, D. W. (2004) · Pharmacogenetics · doi:10.1097/00008571-200401000-00001 · Cited by 1,027
Russell, D. W., & Setchell, K. D. R. (1992) · Biochemistry · doi:10.1021/bi00135a001 · Cited by 819
Li, F., Jiang, C., Krausz, K. W., Li, Y., Albert, I., Hao, H., Fabre, K. M., Mitchell, J. B., Patterson, A. D., & Gonzalez, F. J. (2013) · Nature Communications · doi:10.1038/ncomms3384 · Cited by 705
Self-citationIntestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Jiang, C., Xie, C., Li, F., Zhang, L., Nichols, R. G., Krausz, K. W., Cai, J., Qi, Y., Fang, Z.-Z., Takahashi, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76738 · Cited by 693
Self-citationIntestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
Jiang, C., Xie, C., Lv, Y., Li, J., Krausz, K. W., Shi, J., Brocker, C. N., Desai, D., Amin, S. G., Bisson, W. H., et al. (2015) · Nature Communications · doi:10.1038/ncomms10166 · Cited by 559
Self-citationFXR signaling in the enterohepatic system
Matsubara, T., Li, F., & Gonzalez, F. J. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.05.004 · Cited by 381
Self-citationThe enterohepatic circulation of bile acids in mammals: form and functions
Hofmann, A. (2009) · Frontiers in Bioscience · doi:10.2741/3399 · Cited by 322
Mueller, M., Thorell, A., Claudel, T., Jha, P., Koefeler, H., Lackner, C., Hoesel, B., Fauler, G., Stojakovic, T., Einarsson, C., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.034 · Cited by 312
Detoxification of Lithocholic Acid, A Toxic Bile Acid: Relevance to Drug Hepatotoxicity
Hofmann, A. F. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-200033475 · Cited by 268
Seeley, R. J., Chambers, A. P., & Sandoval, D. A. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.01.001 · Cited by 235
Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism
van Herwaarden, A. E., Wagenaar, E., van der Kruijssen, C. M. M., van Waterschoot, R. A. B., Smit, J. W., Song, J.-Y., van der Valk, M. A., van Tellingen, O., van der Hoorn, J. W. A., Rosing, H., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33435 · Cited by 235
Liver-specific Deletion of the NADPH-Cytochrome P450 Reductase Gene
Gu, J., Weng, Y., Zhang, Q.-Y., Cui, H., Behr, M., Wu, L., Yang, W., Zhang, L., & Ding, X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303125200 · Cited by 214
Transformation of Chenodeoxycholic Acid and Ursodeoxycholic Acid by Human Intestinal Bacteria
Fedorowski, T., Salen, G., Tint, G. S., et al. (1979) · Gastroenterology · doi:10.1016/s0016-5085(79)80079-7 · Cited by 154
Hardison, W. G. M. (1978) · Gastroenterology · doi:10.1016/0016-5085(78)93767-8 · Cited by 149
Cheung, C., & Gonzalez, F. J. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141242 · Cited by 129
Self-citationTanaka, N., Takahashi, S., Zhang, Y., Krausz, K. W., Smith, P. B. W., Patterson, A. D., & Gonzalez, F. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.02.012 · Cited by 123
Self-citationMAFG Is a Transcriptional Repressor of Bile Acid Synthesis and Metabolism
Vallim, T. Q. D. A., Tarling, E. J., Ahn, H., Hagey, L. R., Romanoski, C. E., Lee, R. G., Graham, M. J., Motohashi, H., Yamamoto, M. P., & Edwards, P. A. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.01.007 · Cited by 110
Nuclear Receptor Control of Enterohepatic Circulation
Gonzalez, F. J. (2012) · Comprehensive physiology · doi:10.1002/cphy.c120007 · Cited by 106
Self-citationHIRANO, S., & Masuda, N. (1981) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40663-7 · Cited by 93
Hasegawa, M., Kapelyukh, Y., Tahara, H., Seibler, J., Rode, A., Krueger, S., Lee, D. N., Wolf, C. R., & Scheer, N. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.071845 · Cited by 89
Self-citationThe Metabolism of Chenodeoxycholic Acid to β‐Muricholic Acid in Rat Liver
Botham, K. M., & Boyd, G. S. (1983) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1983.tb07550.x · Cited by 69
Scheer, N., Kapelyukh, Y., McEwan, J., Beuger, V., Stanley, L. A., Rode, A., & Wolf, C. R. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.075192 · Cited by 58
Self-citationScheer, N., Kapelyukh, Y., Chatham, L. R., Rode, A., Buechel, S., & Wolf, C. R. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.080036 · Cited by 55
Self-citationDeo, A. K., & Bandiera, S. M. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.022194 · Cited by 55
Scheer, N., & Wolf, C. R. (2013) · Xenobiotica · doi:10.3109/00498254.2013.815831 · Cited by 50
Self-citationGreathouse, K. L., Harris, C. C., & Bultman, S. J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.016 · Cited by 39
Löfgren, S., Baldwin, R. M., Carlerös, M., Terelius, Y., Fransson-Steen, R., Mwinyi, J., Waxman, D. J., & Ingelman‐Sundberg, M. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.026963 · Cited by 27
Deletion of 30 Murine Cytochrome P450 Genes Results In Viable Mice With Compromised Drug Metabolism
Scheer, N., McLaughlin, L. A., Rode, A., MacLeod, A. K., Henderson, C. J., & Wolf, C. R. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.057885 · Cited by 21
Self-citationJones, R., Lopez, A. M., Tong, E. Y., Posey, K. S., Chuang, J.-C., Repa, J. J., & Turley, S. D. (2014) · Steroids · doi:10.1016/j.steroids.2014.11.002 · Cited by 18
Cheng, X., Zhang, Y., & Klaassen, C. D. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.216796 · Cited by 7
Cited by
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
Sun, L., Xie, C., Wang, G., Wu, Y., Wu, Q., Wang, X., Liu, J., Deng, Y., Xia, J., Chen, B., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0222-4 · Cited by 1,011
Self-citationChávez-Talavera, O., Tailleux, A., Lefebvre, P., & Staels, B. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.055 · Cited by 970
Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy
Chiang, J. Y. L., & Ferrell, J. M. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00223.2019 · Cited by 580
Bile Acid Metabolism in Liver Pathobiology
Chiang, J. Y. L., & Ferrell, J. M. (2018) · Gene Expression · doi:10.3727/105221618x15156018385515 · Cited by 546
Fleishman, J. S., & Kumar, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01811-6 · Cited by 544
Metadata
- Authors
- Takahashi, S., Fukami, T., Masuo, Y., Brocker, C. N., Xie, C., Krausz, K. W., Wolf, C. R., Henderson, C. J., & Gonzalez, F. J.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2016-12
- Volume
- 57
- Issue
- 12
- Pages
- 2130-2137
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2520824290
- Cited by
- 313
- References
- 35
- FWCI
- 23.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.